Home/Filings/4/0001179110-20-000564
4//SEC Filing

Fletcher Robert C. 4

Accession 0001179110-20-000564

CIK 0000861838other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 6:48 PM ET

Size

7.8 KB

Accession

0001179110-20-000564

Insider Transaction Report

Form 4
Period: 2020-01-10
Fletcher Robert C.
Sr. VP, Bus. Dev. & Strategy
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-01-10+50,00050,000 total
    Exercise: $1.79Exp: 2030-01-10Common Stock (50,000 underlying)
  • Award

    Common Stock

    2020-01-10+20,00036,485 total
Footnotes (3)
  • [F1]Represents a restricted stock unit ("RSU") award granted under the Issuer's 2013 Stock Incentive Plan. Each RSU represents a right to receive one share of Issuer common stock. The RSU award vests over a four-year period commencing on January 10, 2020. Twenty-five percent (25%) of the shares subject to the RSU award shall vest on each one-year anniversary of the grant date of the award.
  • [F2]Securities beneficially owned totaling 36,485 includes 2,910 shares of Issuer common stock owned and 33,575 of unvested RSU's held by the reporting person.
  • [F3]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 10, 2020. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 10, 2021 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeother

Related Parties

1
  • filerCIK 0001508231

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 6:48 PM ET
Size
7.8 KB